Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1996-11-08
1997-12-16
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
514 2, 514 21, 514 46, 514 52, 514 59, 514557, A61K 3819, A61K 3119
Patent
active
056982321
ABSTRACT:
An interferon is administered singly or in combination with other pharmacological agents to patients with idiopathic sudden sensorineural hearing loss, whereby the patients are remarkably improved.
REFERENCES:
patent: 5200177 (1993-04-01), Leung
Rote Liste (1991).
Munch. Med. Wschr., vol. 124, No. 42 (1982).
Jibi Rinsho, vol. 75, No. 3, pp. 769-778 (1982).
Am. J. Otol., vol. 10, No. 3, pp. 242-247 (1989).
Laryngoscope, vol. 72, No. 8, pp. 1142-1157 (1962).
Arch. Otorhinolaryngol, vol. 243, pp. 1-15 (1986).
Jibi, vol. 28, pp. 878-884 (1982).
Jibi Rinsho, vol. 81, No. 4, pp. 515-524 (1988).
Virus Research, vol. 15, pp. 1-26 (1990).
Jikou, vol. 57, No. 8, pp. 621-628 (1985).
Fukushima Hideyuki
Kanemaru Shin-ichi
Hoffmann-La Roche Inc.
Kishore Gollamudi S.
Sumitomo Pharmaceuticals Company Ltd.
Takeda Chemical Industries Ltd.
LandOfFree
Pharmaceutical composition for treatment of sudden deafness does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for treatment of sudden deafness, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for treatment of sudden deafness will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-203205